{"url_path":"/sec/enta/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1177648/0001193125-26-220572-index.html","accession_number":"0001193125-26-220572","cik":"0001177648","ticker":"ENTA","issuer_name":"ENANTA PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1177648/0001193125-26-220572-index.html","primary_entity_key":"0001177648","primary_entity_name":"ENANTA PHARMACEUTICALS INC"},"word_count":44,"has_tables":true,"body_markdown":"ITEM 1. LEGAL PROCEEDINGS\n\nInformation with respect to legal proceedings is included in Note 10 of the Notes to the Unaudited Condensed Consolidated Financial Statements contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, which is incorporated herein by reference."}